Cargando…
Treatment regimens for neuromyelitis optica spectrum disorder attacks: a retrospective cohort study
BACKGROUND: Neuromyelitis optica spectrum disorder (NMOSD) attacks require an urgent probabilistic anti-inflammatory therapeutic strategy. As inadequately treated attacks result in disability, there is a need to identify the optimal attack-treatment regimen. Our study aimed to identify predictors of...
Autores principales: | Demuth, Stanislas, Guillaume, Maxime, Bourre, Bertrand, Ciron, Jonathan, Zephir, Hélène, Sirejacob, Yoann, Kerbrat, Anne, Lebrun-Frenay, Christine, Papeix, Caroline, Michel, Laure, Laplaud, David, Vukusic, Sandra, Maillart, Elisabeth, Cohen, Mikael, Audoin, Bertrand, Marignier, Romain, Collongues, Nicolas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892703/ https://www.ncbi.nlm.nih.gov/pubmed/35236386 http://dx.doi.org/10.1186/s12974-022-02420-2 |
Ejemplares similares
-
A meta‐analysis comparing first‐line immunosuppressants in neuromyelitis optica
por: Giovannelli, Jonathan, et al.
Publicado: (2021) -
Outcome and risk of recurrence in a large cohort of idiopathic longitudinally extensive transverse myelitis without AQP4/MOG antibodies
por: Maillart, Elisabeth, et al.
Publicado: (2020) -
Pure Relapsing Short Myelitis: Part of the Multiple Sclerosis Spectrum or New Entity?
por: Poullet, Zélia, et al.
Publicado: (2022) -
Evaluation of treatment response in adults with relapsing MOG-Ab-associated disease
por: Cobo-Calvo, Alvaro, et al.
Publicado: (2019) -
Dramatic efficacy of ofatumumab in refractory pediatric-onset AQP4-IgG neuromyelitis optica spectrum disorder
por: Maillart, Elisabeth, et al.
Publicado: (2020)